• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION RELIANCE 4-FRONT; IMPLANTABLE LEAD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION RELIANCE 4-FRONT; IMPLANTABLE LEAD Back to Search Results
Model Number 0675
Device Problems Signal Artifact/Noise (1036); Pacing Problem (1439); Pocket Stimulation (1463); Low impedance (2285)
Patient Problems Undesired Nerve Stimulation (1980); No Code Available (3191)
Event Date 09/20/2020
Event Type  Injury  
Manufacturer Narrative
(b)(4).The lead has been returned for analysis.This report will be updated upon completion of analysis.
 
Event Description
It was reported that this patient was in the following physicians clinic and this right ventricular (rv) lead was exhibiting a low out of range shock impedance measurement of zero (0), a pace impedance measurement of 259 ohms and the device pocket was exhibiting pocket stimulation.The patient is device therapy dependent.Boston scientific technical services (ts) indicated that there was a previous stored episode in which the associated implantable cardioverter defibrillator (icd) device provided 5 shocks for a true ventricular tachycardia (vt) and the shock impedance was 39 ohms for the delivered shocks.In addition, there was another stored episode that exhibited noise with a 5 second pause in pacing therapy.The current rhythm was noted to be a normal sinus rhythm at a rate of 70 beats per minute (bpm), but the device is still pacing at the lower rate limit of 50 bpm.Ts indicating that it appears the lead is no longer sensing appropriately.Ts discussed with the boston scientific representative (rep) that they are concerned that there is a lead insulation breach, the patient should be considered unprotected and the lead needs to be replaced.The rv lead was subsequently explanted and replaced.No additional adverse patient effects were reported.
 
Event Description
It was reported that this patient was in the following physicians clinic and this right ventricular (rv) lead was exhibiting a low out of range shock impedance measurement of zero (0), a pace impedance measurement of 259 ohms and the device pocket was exhibiting pocket stimulation.The patient is device therapy dependent.Boston scientific technical services (ts) indicated that there was a previous stored episode in which the associated implantable cardioverter defibrillator (icd) device provided five (5) shocks for a true ventricular tachycardia (vt) and the shock impedance was 39 ohms for the delivered shocks.In addition, there was another stored episode that exhibited noise with a five (5) second pause in pacing therapy.The current rhythm was noted to be a normal sinus rhythm at a rate of 70 beats per minute (bpm), but the device is still pacing at the lower rate limit of 50 bpm.Ts indicating that it appears the lead is no longer sensing appropriately.Ts discussed with the boston scientific representative (rep) that they are concerned that there is a lead insulation breach, the patient should be considered unprotected and the lead needs to be replaced.The rv lead was subsequently explanted and replaced.No additional adverse patient effects were reported.
 
Manufacturer Narrative
Patient code 3191 captures the reportable event of surgery.The lead has been returned for analysis.This report will be updated upon completion of analysis.Upon receipt at our post market quality assurance laboratory, a thorough evaluation of the lead was performed.Testing was completed to assess lead electrical performance and inner/outer insulation integrity.Measurements were within normal limits, except the pressure test which failed due to a cut on the outer insulation which likely occurred during the explant procedure.Microscopic inspections of the terminal pin assembly, lead body, and electrode tip found no additional anomalies.Laboratory testing was unable to reproduce the reported clinical observations and detailed analysis did not reveal any abnormalities.Laboratory analysis did not identify any lead characteristics that would have caused or contributed to the reported clinical observations.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RELIANCE 4-FRONT
Type of Device
IMPLANTABLE LEAD
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
MDR Report Key11103720
MDR Text Key224700342
Report Number2124215-2020-24756
Device Sequence Number1
Product Code LWS
UDI-Device Identifier00802526496981
UDI-Public00802526496981
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 05/04/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/02/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date08/20/2021
Device Model Number0675
Device Catalogue Number0675
Device Lot Number502533
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/02/2020
Date Manufacturer Received01/22/2021
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age56 YR
-
-